Vivos Inc. (RDGL) Research

Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an injectable particle-gel that utilizes yttrium-90 for targeted radiation treatment of cancerous growths in both humans and animals. Additionally, the company provides IsoPet, a specific treatment for solid tumors found in animals. Established in 1994, Vivos Inc. is based in Richland, Washington. It previously operated under the name Advanced Medical Isotope Corporation before rebranding to Vivos Inc. in December 2017.

Market snapshot

Symbol
RDGL
Price
$0.06
Day change
-7.09%
Market cap
$31.1M
P/E ratio
-8.51x
52-week range
0.0425-0.1547
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Cannabix Technologies Inc. (BLOZF)
  • The Cannabist Company Holdings Inc. (CBSTF)
  • Cynata Therapeutics Limited (CYYNF)
  • Drug Free Solution, Inc. (DSOL)
  • Nova Eye Medical Limited (ELXMF)
  • MedMira Inc. (MMIRF)
  • Novacyt S.A. (NVYTF)
  • PetVivo Holdings, Inc. (PETV)

Recent insider activity

  • Korenko Michael K — P-Purchase (150000 shares) on 2026-05-11
  • Weeks Brad Allan — trade (0 shares) on 2025-09-15
  • Weeks Brad Allan — trade (500000 shares) on 2027-11-18
  • Korenko Michael K — P-Purchase (200000 shares) on 2025-12-31
  • Korenko Michael K — P-Purchase (100000 shares) on 2025-12-02

Open Vivos Inc. (RDGL) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.